The Scientist

» lncRNA and immunology

Most Recent

image: Novel Hantavirus Infection Method

Novel Hantavirus Infection Method

By | July 3, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: Brrrr-ying the Results

Brrrr-ying the Results

By | July 1, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

1 Comment

image: Diagnosing Ebola in 15 Minutes

Diagnosing Ebola in 15 Minutes

By | June 30, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: Sex Differences in Pain Pathway

Sex Differences in Pain Pathway

By | June 29, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

1 Comment

image: Neutralizing HIV

Neutralizing HIV

By | June 18, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: Brain Drain

Brain Drain

By | June 1, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

3 Comments

image: New Immunity

New Immunity

By | June 1, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: Not So Noncoding

Not So Noncoding

By | June 1, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: Measles Vax’s Off-Target Effects

Measles Vax’s Off-Target Effects

By | May 11, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

2 Comments

image: Outsmarting HIV

Outsmarting HIV

By | May 4, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech